HHS deputy secretary
This article was originally published in The Gray Sheet
Executive Summary
Number-two spot at HHS is appearing to be tough to fill, even though a knowledgeable health policy insider could have a lot of influence in Thompson's HHS. Lobbyist and Bush advisor Deborah Steelman told "In the Loop" column in The Washington Post on Jan. 19 that she had turned the job down on Jan. 16 after initially agreeing. Among other former Republican health policy people said to have been contacted by Bush personnel hunters is Bayer Washington rep Ron Docksai; Project Hope's Gail Wilensky and Sheila Burke, former Sen. Dole health policy expert and current undersecretary for American museums, programs and national outreach at the Smithsonian
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.